Movement Alert｜IQVIA Rises 8.48% in Regular Trading, Multiple Banks Raise Price Targets Ahead of Q2 Earnings

Market Focus

Jul 23

On July 23, IQVIA rose 8.48% in regular trading, trading at $216.56/share, with turnover of $1.9769 million. The rally was driven by a wave of investment bank target price upgrades combined with pre-earnings positioning ahead of the July 28 Q2 report.

Multiple brokerages raised their price targets in recent weeks: Baird lifted its target to $252, HSBC and Leerink Partners both raised to $240, Mizuho moved to $230, and Evercore ISI raised to $225 — all maintaining bullish ratings. The consensus mean target now stands at approximately $228.50. Market expectations for Q2 adjusted EPS are $2.72, representing growth from $2.90 reported in Q1 which beat estimates by 2.84%.

The broader Life Sciences Tools and Services sector rallied in tandem, with Medpace surging 26.87%, Thermo Fisher Scientific up 9.85%, West Pharmaceutical up 5.51%, Waters up 4.26%, and Danaher up 3.62%, forming sector-wide momentum. Management previously guided full-year revenue of $17.15 billion to $17.35 billion, with AI enablement and clinical trial recovery underpinning the medium-term growth thesis.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1182867208"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1182867208\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1182867208?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-23 21:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182867208","market":"hk","top_or_hot":-1,"title":"Movement Alert｜IQVIA Rises 8.48% in Regular Trading, Multiple Banks Raise Price Targets Ahead of Q2 Earnings","media":"Market Focus","content":"<p><p>On July 23, IQVIA rose 8.48% in regular trading, trading at $216.56/share, with turnover of $1.9769 million. The rally was driven by a wave of investment bank target price upgrades combined with pre-earnings positioning ahead of the July 28 Q2 report.</p><p>Multiple brokerages raised their price targets in recent weeks: Baird lifted its target to $252, HSBC and Leerink Partners both raised to $240, Mizuho moved to $230, and Evercore ISI raised to $225 — all maintaining bullish ratings. The consensus mean target now stands at approximately $228.50. Market expectations for Q2 adjusted EPS are $2.72, representing growth from $2.90 reported in Q1 which beat estimates by 2.84%.</p><p>The broader Life Sciences Tools and Services sector rallied in tandem, with Medpace surging 26.87%, Thermo Fisher Scientific up 9.85%, West Pharmaceutical up 5.51%, Waters up 4.26%, and Danaher up 3.62%, forming sector-wide momentum. Management previously guided full-year revenue of $17.15 billion to $17.35 billion, with AI enablement and clinical trial recovery underpinning the medium-term growth thesis.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜IQVIA Rises 8.48% in Regular Trading, Multiple Banks Raise Price Targets Ahead of Q2 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜IQVIA Rises 8.48% in Regular Trading, Multiple Banks Raise Price Targets Ahead of Q2 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-23 21:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 23, IQVIA rose 8.48% in regular trading, trading at $216.56/share, with turnover of $1.9769 million. The rally was driven by a wave of investment bank target price upgrades combined with pre-earnings positioning ahead of the July 28 Q2 report.</p><p>Multiple brokerages raised their price targets in recent weeks: Baird lifted its target to $252, HSBC and Leerink Partners both raised to $240, Mizuho moved to $230, and Evercore ISI raised to $225 — all maintaining bullish ratings. The consensus mean target now stands at approximately $228.50. Market expectations for Q2 adjusted EPS are $2.72, representing growth from $2.90 reported in Q1 which beat estimates by 2.84%.</p><p>The broader Life Sciences Tools and Services sector rallied in tandem, with Medpace surging 26.87%, Thermo Fisher Scientific up 9.85%, West Pharmaceutical up 5.51%, Waters up 4.26%, and Danaher up 3.62%, forming sector-wide momentum. Management previously guided full-year revenue of $17.15 billion to $17.35 billion, with AI enablement and clinical trial recovery underpinning the medium-term growth thesis.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IQV","symbol_name":"艾昆纬","start_time":0,"source_url":"","article_id":"1182867208","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182867208","pubTimestamp":1784813536,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 23, IQVIA rose 8.48% in regular trading, trading at $216.56/share, with turnover of $1.9769 million. The rally was driven by a wave of investment bank target price upgrades combined with...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IQV":"艾昆纬"},"translate_title":"走势警报|IQVIA 常规交易中上涨 8.48%，多家银行在第二季度财报公布前上调目标价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IQV":1},"content_text":"On July 23, IQVIA rose 8.48% in regular trading, trading at $216.56/share, with turnover of $1.9769 million. The rally was driven by a wave of investment bank target price upgrades combined with pre-earnings positioning ahead of the July 28 Q2 report.Multiple brokerages raised their price targets in recent weeks: Baird lifted its target to $252, HSBC and Leerink Partners both raised to $240, Mizuho moved to $230, and Evercore ISI raised to $225 — all maintaining bullish ratings. The consensus mean target now stands at approximately $228.50. Market expectations for Q2 adjusted EPS are $2.72, representing growth from $2.90 reported in Q1 which beat estimates by 2.84%.The broader Life Sciences Tools and Services sector rallied in tandem, with Medpace surging 26.87%, Thermo Fisher Scientific up 9.85%, West Pharmaceutical up 5.51%, Waters up 4.26%, and Danaher up 3.62%, forming sector-wide momentum. Management previously guided full-year revenue of $17.15 billion to $17.35 billion, with AI enablement and clinical trial recovery underpinning the medium-term growth thesis.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}